103 related articles for article (PubMed ID: 24438049)
21. The clinical impact of the American College of Surgeons Oncology Group Z-0011 trial--results from the BreastSurgANZ National Breast Cancer Audit.
Ainsworth RK; Kollias J; Le Blanc A; De Silva P
Breast; 2013 Oct; 22(5):733-5. PubMed ID: 23290275
[TBL] [Abstract][Full Text] [Related]
22. Treatment patterns for female breast cancer in Minnesota, 1995-1996.
Miller N; Bushhouse S
Minn Med; 2003 Dec; 86(12):26-31. PubMed ID: 14719613
[TBL] [Abstract][Full Text] [Related]
23. Repeat surgery following breast conservation and intra-operative sentinel lymph node analysis for breast cancer.
Dabbas N; Cutress RI; Wise M; Yiangou C; Agrawal A
Surgeon; 2013 Oct; 11(5):235-40. PubMed ID: 23453370
[TBL] [Abstract][Full Text] [Related]
24. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
[TBL] [Abstract][Full Text] [Related]
25. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
26. Indicators of loco-regional recurrence in breast cancer. The South East Swedish Breast Cancer Group.
Sundquist M; Thorstenson S; Klintenberg C; Brudin L; Nordenskjöld B
Eur J Surg Oncol; 2000 Jun; 26(4):357-62. PubMed ID: 10873355
[TBL] [Abstract][Full Text] [Related]
27. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
[TBL] [Abstract][Full Text] [Related]
28. Profile of prognostic factors in 1022 Indian women with early-stage breast cancer treated with breast-conserving therapy.
Dinshaw KA; Budrukkar AN; Chinoy RF; Sarin R; Badwe R; Hawaldar R; Shrivastava SK
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1132-41. PubMed ID: 15978744
[TBL] [Abstract][Full Text] [Related]
29. Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer.
Ejlertsen B; Jensen MB; Rank F; Rasmussen BB; Christiansen P; Kroman N; Kvistgaard ME; Overgaard M; Toftdahl DB; Mouridsen HT;
J Natl Cancer Inst; 2009 May; 101(10):729-35. PubMed ID: 19436035
[TBL] [Abstract][Full Text] [Related]
30. Analysing risk factors for poorer breast cancer outcomes in residents of lower socioeconomic areas of Australia.
Roder D; Zorbas HM; Kollias J; Pyke CM; Walters D; Campbell ID; Taylor C; Webster F
Aust Health Rev; 2014 May; 38(2):134-41. PubMed ID: 24709287
[TBL] [Abstract][Full Text] [Related]
31. The effect of dedicated breast surgeons on the short-term outcomes in breast cancer.
Zork NM; Komenaka IK; Pennington RE; Bowling MW; Norton LE; Clare SE; Goulet RJ
Ann Surg; 2008 Aug; 248(2):280-5. PubMed ID: 18650639
[TBL] [Abstract][Full Text] [Related]
32. Who should not undergo breast conservation?
Nijenhuis MV; Rutgers EJ
Breast; 2013 Aug; 22 Suppl 2():S110-4. PubMed ID: 24074770
[TBL] [Abstract][Full Text] [Related]
33. Is lymphovascular invasion degree one of the important factors to predict neoadjuvant chemotherapy efficacy in breast cancer?
Uematsu T; Kasami M; Watanabe J; Takahashi K; Yamasaki S; Tanaka K; Tadokoro Y; Ogiya A
Breast Cancer; 2011 Oct; 18(4):309-13. PubMed ID: 20574730
[TBL] [Abstract][Full Text] [Related]
34. Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: patterns of failure and prognostic factors.
Chen X; Yu X; Chen J; Zhang Z; Tuan J; Shao Z; Guo X; Feng Y
Cancer; 2013 Jul; 119(13):2366-74. PubMed ID: 23576181
[TBL] [Abstract][Full Text] [Related]
35. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
[TBL] [Abstract][Full Text] [Related]
36. The impact of method of biopsy on the incidence of breast cancer sentinel lymph node metastases.
Meattini I; Giannotti E; Abdulcadir D; Saieva C; Guerrieri AM; Vanzi E; Scartoni D; Cecchini S; Sanchez LJ; Orzalesi L; Casella D; Bianchi S; Livi L; Nori J
Eur J Surg Oncol; 2014 Mar; 40(3):277-81. PubMed ID: 24388742
[TBL] [Abstract][Full Text] [Related]
37. Consequences of axillary recurrence after conservative breast surgery.
Fredriksson I; Liljegren G; Arnesson LG; Emdin SO; Palm-Sjövall M; Fornander T; Holmqvist M; Holmberg L; Frisell J
Br J Surg; 2002 Jul; 89(7):902-8. PubMed ID: 12081741
[TBL] [Abstract][Full Text] [Related]
38. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY
Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262
[TBL] [Abstract][Full Text] [Related]
39. [Surgical aspects of breast cancer screening at our hospital].
Márkus B; Bajner A; Csejtei A; Firisz B; Hegedus A; Kocsis E; Kovács B; Pintér G; Tóth C
Magy Seb; 2006 Oct; 59(5):375-82. PubMed ID: 17201346
[TBL] [Abstract][Full Text] [Related]
40. Significance of local recurrence as a prognostic factor in the treatment of breast cancer.
Horiguchi J; Koibuchi Y; Yoshida T; Takata D; Kikuchi M; Rokutanda N; Nagaoka R; Iino Y; Morishita Y
Anticancer Res; 2006; 26(1B):569-73. PubMed ID: 16739322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
